Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
PHILADELPHIA, February 28, 2013 /PRNewswire/ --
Integrated clinical solutions from Elsevier, including new order sets, work to help healthcare providers achieve clinical, operational and financial excellence
Elsevier, a world-leading provider of scientific, technical and medical information products and services, has aligned its clinical decision support (CDS) and clinical reference solutions to help healthcare providers and payers achieve clinical, operational and financial excellence.
The latest example of this alignment is InOrder by Elsevier, an intuitive, cloud-based order set solution that enables clinicians to author, review and publish orders in a collaborative environment that quickly translates evidence-based knowledge into better patient care. By combining Elsevier's deep experience in providing evidence-based content and the capability to make updates rapidly as regulations and medications change, InOrder can help hospitals and clinicians increase patient safety and prevent medical errors.
"From analytics and reporting to evidence-based clinical information delivery, clinical practice transformation and patient education, Elsevier empowers meaningful care by providing a patient-centered approach to helping organizations achieve clinical, operational and financial excellence," said Jay Katzen, President of Elsevier's clinical solutions business. "As the healthcare industry continues to evolve, we are working hard to make it easier for providers and payers to achieve their best performance."
Elsevier will demonstrate its integrated solutions at its booth (#6129) at the Healthcare Information Management and Systems Society (HIMSS13) annual meeting in New Orleans, March 4-6. Using a patient-centered approach, Elsevier has aligned an integrated suite of capabilities for healthcare providers unmatched in the industry:
Also at HIMSS13, Elsevier will present several new and enhanced product solutions:
Two of Elsevier's nationally known thought leaders will be active at HIMSS13. Dr. Teich will present the closing keynote - "The Future of Healthcare Innovation" - at the HIMSS Innovation Symposium on Sunday, March 3. And Michelle Troseth, MSN, RN, DPNAP, FAANRN, Elsevier's Chief Professional Practice Officer, will co-present a HIMSS Educational Session on "TIGER IMPACT: Measuring VLE Metrics and More of the TIGER Story!" on Monday, March 4.
For details on these and other Elsevier presentations, see the complete list at http://www.clinicaldecisionsupport.com/himss13
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Director, Corporate Relations
©2012 PR Newswire. All Rights Reserved.